{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:48:51Z","timestamp":1785606531081,"version":"3.56.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Despite higher atherosclerotic cardiovascular disease (ASCVD) risk, people with HIV (PWH) experience unique barriers to ASCVD prevention, such as changing models of HIV primary care.<\/jats:p><\/jats:sec>Objective<\/jats:title>To test whether a multicomponent nurse-led strategy would improve systolic blood pressure (SBP) and non\u2013high-density lipoprotein (HDL) cholesterol level in a diverse population of PWH receiving antiretroviral therapy (ART).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This randomized clinical trial enrolled PWH at 3 academic HIV clinics in the US from September 2019 to January 2022 and conducted follow-up for 12 months until January 2023. Included patients were 18 years or older and had a confirmed HIV diagnosis, an HIV-1 viral load less than 200 copies\/mL, and both hypertension and hypercholesterolemia. Participants were stratified by trial site and randomized 1:1 to either the multicomponent EXTRA-CVD (A Nurse-Led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention) intervention group or the control group. Primary analyses were conducted according to the intention-to-treat principle.<\/jats:p><\/jats:sec>Intervention<\/jats:title>The EXTRA-CVD group received home BP monitoring guidance and BP and cholesterol management from a dedicated prevention nurse at 4 in-person visits (baseline and 4, 8, and 12 months) and frequent telephone check-ins up to every 2 weeks as needed. The control group received general prevention education sessions from the prevention nurse at each of the 4 in-person visits.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Study-measured SBP was the primary outcome, and non\u2013HDL cholesterol level was the secondary outcome. Measurements were taken over 12 months and assessed by linear mixed models. Prespecified moderators tested were sex at birth, baseline ASCVD risk, and trial site.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 297 PWH were randomized to the EXTRA-CVD arm (n\u2009=\u2009149) or control arm (n\u2009=\u2009148). Participants had a median (IQR) age of 59.0 (53.0-65.0) years and included 234 males (78.8%). Baseline mean (SD) SBP was 135.0 (18.8) mm Hg and non\u2013HDL cholesterol level was 139.9 (44.6) mg\/dL. At 12 months, participants in the EXTRA-CVD arm had a clinically significant 4.2-mm Hg (95% CI, 0.3-8.2 mm Hg; P<\/jats:italic>\u2009=\u2009.04) lower SBP and 16.9-mg\/dL (95% CI, 8.6-25.2 mg\/dL; P<\/jats:italic>\u2009&amp;lt;\u2009.001) lower non\u2013HDL cholesterol level compared with participants in the control arm. There was a clinically meaningful but not statistically significant difference in SBP effect in females compared with males (11.8\u2013mm Hg greater difference at 4 months, 9.6 mm Hg at 8 months, and 5.9 mm Hg at 12 months; overall joint test P<\/jats:italic>\u2009=\u2009.06).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Results of this trial indicate that the EXTRA-CVD strategy effectively reduced BP and cholesterol level over 12 months and should inform future implementation of multifaceted ASCVD prevention programs for PWH.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03643705<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.56445","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:16:23Z","timestamp":1709655383000},"page":"e2356445","source":"Crossref","is-referenced-by-count":18,"title":["Nurse-Led Strategy to Improve Blood Pressure and Cholesterol Level Among People With HIV"],"prefix":"10.1001","volume":"7","author":[{"given":"Christopher T.","family":"Longenecker","sequence":"first","affiliation":[{"name":"University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrilynn O.","family":"Hileman","sequence":"additional","affiliation":[{"name":"MetroHealth Medical Center, Cleveland, Ohio"},{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwora Lance","family":"Okeke","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Gripshover","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Aifah","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Muiruri","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"},{"name":"Durham Veterans Affairs Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Vedanthan","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Webel","sequence":"additional","affiliation":[{"name":"University of Washington School of Nursing, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden B.","family":"Bosworth","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"},{"name":"Durham Veterans Affairs Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"2","key":"zoi231661r1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pcad.2020.02.011","article-title":"Prevention as treatment: a bold vision for improving the cardiovascular health of people living with HIV.","volume":"63","author":"Longenecker","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"zoi231661r2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43058-021-00114-z","article-title":"Understanding constraints on integrated care for people with HIV and multimorbid cardiovascular conditions: an application of the Theoretical Domains Framework.","volume":"2","author":"Schexnayder","year":"2021","journal-title":"Implement Sci Commun"},{"issue":"5","key":"zoi231661r3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/QAI.0000000000002290","article-title":"Impact of perceived cardiovascular risk on cardiovascular disease prevention behaviors in people with and without HIV infection.","volume":"83","author":"Webel","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"zoi231661r4","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"key":"zoi231661r5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ahj.2022.03.006","article-title":"Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.","volume":"249","author":"Erqou","year":"2022","journal-title":"Am Heart J"},{"issue":"11","key":"zoi231661r6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007107","article-title":"Disparities in the quality of cardiovascular care between HIV-infected versus HIV-uninfected adults in the United States: a cross-sectional study.","volume":"6","author":"Ladapo","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"zoi231661r7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/hiv.v23.3","article-title":"Statin usage and cardiovascular risk among people living with HIV in the U.S. Military HIV Natural History Study.","volume":"23","author":"Larson","year":"2022","journal-title":"HIV Med"},{"issue":"2","key":"zoi231661r8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pcad.2020.02.013","article-title":"Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.","volume":"63","author":"Aifah","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"zoi231661r9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5334\/gh.856","article-title":"Effect of nurse-based management of hypertension in rural western Kenya.","volume":"15","author":"Vedanthan","year":"2020","journal-title":"Glob Heart"},{"issue":"1","key":"zoi231661r10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1186\/s12913-023-09603-4","article-title":"Training primary healthcare workers on a task-strengthening strategy for integrating hypertension management into HIV care in Nigeria: implementation strategies, knowledge uptake, and lessons learned.","volume":"23","author":"Oladele","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"zoi231661r11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007331.pub3","article-title":"Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.","author":"Kredo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"zoi231661r12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/archinternmed.2011.276","article-title":"Home blood pressure management and improved blood pressure control: results from a randomized controlled trial.","volume":"171","author":"Bosworth","year":"2011","journal-title":"Arch Intern Med"},{"issue":"10","key":"zoi231661r13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7326\/0000605-200911170-00148","article-title":"Two self-management interventions to improve hypertension control: a randomized trial.","volume":"151","author":"Bosworth","year":"2009","journal-title":"Ann Intern Med"},{"key":"zoi231661r14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ahj.2019.07.005","article-title":"Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).","volume":"216","author":"Okeke","year":"2019","journal-title":"Am Heart J"},{"issue":"6","key":"zoi231661r15","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"25","key":"zoi231661r18","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"zoi231661r19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2.","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"25","key":"zoi231661r20","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"zoi231661r21","doi-asserted-by":"publisher","first-page":"f5680","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.","volume":"347","author":"Ninomiya","year":"2013","journal-title":"BMJ"},{"issue":"12","key":"zoi231661r22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis.","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"14","key":"zoi231661r23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A cluster-randomized trial of blood-pressure reduction in Black barbershops.","volume":"378","author":"Victor","year":"2018","journal-title":"N Engl J Med"},{"issue":"10339","key":"zoi231661r24","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","article-title":"A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial.","volume":"399","author":"Sun","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"zoi231661r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12397","article-title":"Effect of lifestyle coaching or enhanced pharmacotherapy on blood pressure control among Black adults with persistent uncontrolled hypertension: a cluster randomized clinical trial.","volume":"5","author":"Nguyen-Huynh","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi231661r26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection.","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi231661r27","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa361","article-title":"Cardiovascular disease risk management in persons with HIV: does clinician specialty matter?","volume":"7","author":"Okeke","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"zoi231661r28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2147\/PPA.S254882","article-title":"Why do people living with HIV adhere to antiretroviral therapy and not comorbid cardiovascular disease medications? a qualitative inquiry.","volume":"14","author":"Muiruri","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"zoi231661r29","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1186\/s12889-020-09896-8","article-title":"The influence of healthcare financing on cardiovascular disease prevention in people living with HIV.","volume":"20","author":"Webel","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"zoi231661r30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12913-022-08015-0","article-title":"Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study.","volume":"22","author":"Muiruri","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"zoi231661r31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/COH.0000000000000756","article-title":"Cardiovascular disease risk in women living with HIV.","volume":"17","author":"Kentoffio","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"zoi231661r17","author":"Webel","year":"2016"},{"key":"zoi231661r16","unstructured":"Case Western Reserve University. Motivational interviewing. Accessed August 15, 2023. https:\/\/case.edu\/socialwork\/centerforebp\/practices\/motivational-interviewing"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815688\/longenecker_2024_oi_231661_1708613290.66182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:16:28Z","timestamp":1709655388000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815688"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.56445","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}